$29.50
1.886.81%
Last update: Nov 6, 6:34 PM
Amylyx Pharmaceuticals Inc
AMLXNASDAQ
The average analyst price target for Amylyx Pharmaceuticals is $28.92, 4.1% below the current price. Of 11 analysts, 10 rate it Buy and 1 Hold. Targets range from $4 to $57. The latest change came on Oct 15, 2026, when Citigroup raised its price target on Amylyx Pharmaceuticals from $32 to $39 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
